CA2113587A1 - Vasoocculsion device containing radiopaque fibers - Google Patents
Vasoocculsion device containing radiopaque fibersInfo
- Publication number
- CA2113587A1 CA2113587A1 CA002113587A CA2113587A CA2113587A1 CA 2113587 A1 CA2113587 A1 CA 2113587A1 CA 002113587 A CA002113587 A CA 002113587A CA 2113587 A CA2113587 A CA 2113587A CA 2113587 A1 CA2113587 A1 CA 2113587A1
- Authority
- CA
- Canada
- Prior art keywords
- fibers
- braided
- radiopaque
- radiolucent
- tubular member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
Abstract
ABSTRACT OF THE INVENTION
This invention is a vasoocclusive device. More particularly, it is a tubular vasoocclusion braid woven from at least radiopaque fibers. The braid may also be partially woven from radiolucent fibers. Optionally, the device may contain a fibrous center or wick in its interior. The device may be continuous or segmented and a fibrous covering or element may be attached.
This invention is a vasoocclusive device. More particularly, it is a tubular vasoocclusion braid woven from at least radiopaque fibers. The braid may also be partially woven from radiolucent fibers. Optionally, the device may contain a fibrous center or wick in its interior. The device may be continuous or segmented and a fibrous covering or element may be attached.
Description
2113~87 , ;~ , ,~
. .
~ 5 VASOOCCLUSION DEVIC~ CONTAINING RADIOPAOU~ FIBERS
: 1 .
~ . .
Field of the I~ve~ion This invention is a vasoocclusive device. More particularly, it 18 a tubular vasoocclusion braid woven I from at least radiopaque fibers. The braid may also be partlally woven from radiolucent fibers. Optionally, the device may contain a flbrous center or wick in it i 15 interior. The device may be continuous or segmented and a fibrous covering or element may be attached.
Background of the Invention Vasoocclusion devices are surgical implements that are placed within the vascuIature of the human body, typically via a catheter, either to block the flow of blood through the vessel making-up that portion of the vasculature or to fonm a clot within an aneurysm stemming fron the vessel. one widely used vasoocclusive device is a helical wire coil having windings that are dimensioned to engage the walls of the vessels. Fibers may also be woven or laid crosswise through the windings to provide a sub~trate for clot formation and tissue growth within the chosen site. Coils having such a structure are readily commercially available.
U.S. Patent N`umber 4,994,069, to Richart et al., de w ribes a vasoocclusive coil which assume~ a ~i linear helical configuration when stretched, and a folded J, convoluted configuration ~hen relaxed. The coil is i 35 introduced into the human body in a stretched condition.
.~ .
2113a87 . .
When the coil reaches its intended site, the coil assumes its relaxed condition -- which is better suited to occlude the vessel -- and restricts blood flow beyond the space that it occupies.
U.S. Patent No. 5,226,gl1 to Chee et al.
teaches a helical vasoocclusion coil to which fibrous elements are attached in such a way that they will not be dislodged from the coil. The fibrous elements enhance the ability of the coil to fill space within the vasculature and to facilitate clot formation and tissue growth.
Care must be taken in creating combination fibroue vasoocclusive elements, i.e., those containing multiple cores and fibrous elements, since the fibrous elements may come off and migrate to vessels supplying blood to normal tissue. Fibrous elements, since they are not normally radiopaque, are difficult to find and to retrieve if separated from the metallic coil.
Nevertheless, it is desireable to increase the ratio of ---fibrou~ element to the metallic coil since the fibrous element increases the tendency of the coil assembly to --cause embolic and tissue growth. --The inventive vasoocclusive braid is desireable in that the ratio of fibrous material to metallic ---material is quite high, the fibrous material is held firmly in place due to the braided or woven configuration, and is easily placed within the body's vasculature.
Sun~K~c~ of the I~yen~Qa This inventlon is a vasoocclusive device comprising:
(a) a braided member which may be segmented, contlnuous, or segmented having a gap between the two end portion~, but ln each case having a first end and a 2113~7 ~ `
second end and woven at least from radiopaque fibers but optionally partially woven from radiolucent fibers; and optionally (b) at lea~t one fibrous woven element or 5 covering attached to the exterior of the braid, and -(c) a fibrous wick or center as the core of the braided member.
Brief De~c~ie~ion of the ~rawings Figure 1 is a ~chematic depiction of an overall system for introducing the inventive devices into the vessel of a human body.
Figures 2-5 are side views, partial cross-sectional side view~, or partial cutaway sideviews of a number of embadiments of the inventive vasoocclusive device.
Descri~tion o$ the Invention The vasoocclusive devices of this invention may be used in a manner similar to those described in U.S.
Pat. No. 4,994,069. Briefly, the inventive devices may be supplied in a pre-pac~aged form in a sterile cannula which is adapted to engage the prox;mAl end of a catheter. As is sho~n in Figure 1, once the catheter (100) is in place ~ithin a vessel (102) -- for instance, the distal end (104) of the catheter llOO) at an aneurysm ~106) -- the braid-containing cannula is placed into engagement with the proximal end of the catheter and the braide are transferred from the cannula lumen into the catheter lumen by exerting force on the proximal end of the coil. A flexible pu~her device ~10~) may be used to push the braid ~110) through the catheter ~100) to the deeired relea~e slte. The location o~ the braide ~110) may be observed due to the radiopaclty o~ the metallic etrands in the braid. Once at the eite, the braids are ., " ~
. .
~ 5 VASOOCCLUSION DEVIC~ CONTAINING RADIOPAOU~ FIBERS
: 1 .
~ . .
Field of the I~ve~ion This invention is a vasoocclusive device. More particularly, it 18 a tubular vasoocclusion braid woven I from at least radiopaque fibers. The braid may also be partlally woven from radiolucent fibers. Optionally, the device may contain a flbrous center or wick in it i 15 interior. The device may be continuous or segmented and a fibrous covering or element may be attached.
Background of the Invention Vasoocclusion devices are surgical implements that are placed within the vascuIature of the human body, typically via a catheter, either to block the flow of blood through the vessel making-up that portion of the vasculature or to fonm a clot within an aneurysm stemming fron the vessel. one widely used vasoocclusive device is a helical wire coil having windings that are dimensioned to engage the walls of the vessels. Fibers may also be woven or laid crosswise through the windings to provide a sub~trate for clot formation and tissue growth within the chosen site. Coils having such a structure are readily commercially available.
U.S. Patent N`umber 4,994,069, to Richart et al., de w ribes a vasoocclusive coil which assume~ a ~i linear helical configuration when stretched, and a folded J, convoluted configuration ~hen relaxed. The coil is i 35 introduced into the human body in a stretched condition.
.~ .
2113a87 . .
When the coil reaches its intended site, the coil assumes its relaxed condition -- which is better suited to occlude the vessel -- and restricts blood flow beyond the space that it occupies.
U.S. Patent No. 5,226,gl1 to Chee et al.
teaches a helical vasoocclusion coil to which fibrous elements are attached in such a way that they will not be dislodged from the coil. The fibrous elements enhance the ability of the coil to fill space within the vasculature and to facilitate clot formation and tissue growth.
Care must be taken in creating combination fibroue vasoocclusive elements, i.e., those containing multiple cores and fibrous elements, since the fibrous elements may come off and migrate to vessels supplying blood to normal tissue. Fibrous elements, since they are not normally radiopaque, are difficult to find and to retrieve if separated from the metallic coil.
Nevertheless, it is desireable to increase the ratio of ---fibrou~ element to the metallic coil since the fibrous element increases the tendency of the coil assembly to --cause embolic and tissue growth. --The inventive vasoocclusive braid is desireable in that the ratio of fibrous material to metallic ---material is quite high, the fibrous material is held firmly in place due to the braided or woven configuration, and is easily placed within the body's vasculature.
Sun~K~c~ of the I~yen~Qa This inventlon is a vasoocclusive device comprising:
(a) a braided member which may be segmented, contlnuous, or segmented having a gap between the two end portion~, but ln each case having a first end and a 2113~7 ~ `
second end and woven at least from radiopaque fibers but optionally partially woven from radiolucent fibers; and optionally (b) at lea~t one fibrous woven element or 5 covering attached to the exterior of the braid, and -(c) a fibrous wick or center as the core of the braided member.
Brief De~c~ie~ion of the ~rawings Figure 1 is a ~chematic depiction of an overall system for introducing the inventive devices into the vessel of a human body.
Figures 2-5 are side views, partial cross-sectional side view~, or partial cutaway sideviews of a number of embadiments of the inventive vasoocclusive device.
Descri~tion o$ the Invention The vasoocclusive devices of this invention may be used in a manner similar to those described in U.S.
Pat. No. 4,994,069. Briefly, the inventive devices may be supplied in a pre-pac~aged form in a sterile cannula which is adapted to engage the prox;mAl end of a catheter. As is sho~n in Figure 1, once the catheter (100) is in place ~ithin a vessel (102) -- for instance, the distal end (104) of the catheter llOO) at an aneurysm ~106) -- the braid-containing cannula is placed into engagement with the proximal end of the catheter and the braide are transferred from the cannula lumen into the catheter lumen by exerting force on the proximal end of the coil. A flexible pu~her device ~10~) may be used to push the braid ~110) through the catheter ~100) to the deeired relea~e slte. The location o~ the braide ~110) may be observed due to the radiopaclty o~ the metallic etrands in the braid. Once at the eite, the braids are ., " ~
2~13~87 singly plunged from the catheter lumen into the ve~sel qite (106). ~ -Figure 2 depicts one embodiment of the va~oocclusive braid of the invention, generally ~hown as (120). The vasoocclusive device (120) has several component~: a first end (122), a ~econd end (124), and a braided or woven tubular fibrous element (126) extending from the first end (122) to a similar position on the second end (124). The tubular element (126) may be made up completely or partially of regular or randomly included radiopaque wlres (128) and optionally may be partially woven of, or cowoven with, radiolucent fibers or wires (130). The braided member may be woven using known weaving techniques and devices to form the tubular member (126) shown in this and the other figures.
Caps (122) and (124), variously in this configuration and in the others discussed herein, may be made of a radiopaque material such as platinum, tungsten, gold, silver, or alloys thereof, or other suitable generally radiopaque metals which are otherwise biologically inert. Radiopacity for the cap~ (122) and (124) is, of course, optional since the braid itself --contains radiopaque wires. The caps ~122) and (124) may be produced from a polymeric material or glue which seals the wires into the fibrous tubular element and keeps it from unraveling.
The diameter of the wire or fiber used in production of the braid will typically be in the range of 0.0005 and 0.005 lnches. The resulting woven braid diameter will normally be 0.008 to 0.018 inches.
Preferably, the braid diameter is 0.015 to 0.018 inches.
The wire may be a radlopaque material such as a metal or polymer, which polymer may be filled with a radiopaque material such a~ po~dered tantalum. Suitable metals and alloys include the platinum group metals especially 21135~7 platinum, rhodium, palladium, and tungsten, gold, silver, ~ tantalum, or alloys thereof. Preferred is a platinum-s tungsten alloy.
The wire may also be any of a variety of 5 stainless steels but may be made of other appropriate ~ materials including shape memory or highly elastic alloys i such as nickel-titanium alloys (48-58 atomic % nickel and 3 optionally containing modest amounts of iron); copper-zinc alloys (38.5-41.5 weight % zinc); copper-zinc alloys 10 containing 1-10 weight ~ of beryllium, silicon, tin, aluminum, or gallium; or nickel-aluminum alloys (36-38 atomic ~ aluminum). Particularly preferred are the alloy3 described in U.S. Pat Nos. 3,174,851, 3,351,463, and 3,753,700. Bspecially preferred is the Ti-Ni alloy 15 known as nitinol. Nitinol wire having the proper transition temperature allows the device to be introduced through the catheter in a linear fashion and upon raising the temperature of the vasoocclusive braid to body temperature, the wire in that braid assumes its pre-20 selected shape.
The radiolucent fibers may be made from biocompatible materials such as Dacron (polyester~, polyglycolic acid, polylactic acid, fluoropolymers (polytetrafluoroethylene), Nylon (polyamide), or silk.
25 The strands forming the braid should be reasonably heavy, e.g., having tensile strength of greater than about 0.15 pounds. Preferred materials are Dacron strands.
¦ The fibrous elements incorporated into the braid may be a bundle of individual fibers, e.g., between 30 5 and 100 flbers per fibrous bundle, preferably 20 to 30 fibers per bundle, or may be monofilaments.
The axial length of the braid will usually be in the range of 0.5 to 100 cm, more usually 2.5 to 40 cm.
Figure 3 shows another varlatlon of the inventive vasoocclusive device (140). In this variation, .. , ... ~
: , ,. . .~ . ~ . . .
2113587 ~
the tubular braid (142) contains a slightly higher incidence of radiopaque wires (12 a ) than the braid shown in Figure 2. This aspect is ~hown merely for the purpose of illustration. A3 noted above, the intent is to include at least radiopaque elements and optionally radiolucent elements which enhance the embolic features of the inventive braid. More importantly, Figure 3 shows the use of outlying fibers (144) which have been tied (or otherwise attached) to the tubular braid fibers. These fibers (144) are tied at various intervals to increase the propensity of the device to occlude blood. The outlying fibers (144) are typically Dacron but may be any of the natural and manmade fibers listed above.
Figure 4 shows another variation (150) of the inventive device in which tassels (152) are tied to the tubular braid to increase the breadth of the device and increase its overall clotting ability. These tassels are typically Dacron but, again, may be any of the fibrous materials described above. The tassels (152) may be short or long and may be singular or multiple depending upon the use intended.
Figure 5 shows a cutaway sideview of the invenSive device in which the braided tubular vasoocclusion device discussed above contains a core of radiolucent fibers. Although the fibers making up the braided tube may be radiolucent or radiopaque, the radiopaque fibers are preferred. The interior core of the braided tubular occlusion device (154) contains a bundle of radiolucent fibers (156) extending from one end of the braided tube to the other. The fiber bundle may be made up of fibers selected from those thermoplastics and natural materials noted above. The ends of the bundle may be ~ealed by heating those ends where the material~ 80 allow. The bundle may be pre-filled or infused with drugs ~ultable for later hastening of . , : : ,, ; . - . - .:
~, . . . .
coagulation after the device i8 introduced into the selected vascular site. The vasoocclusive device of IFigure 5 may also have outlying fibers attached to the !braided tubular element as has been discussed generally ! 5 above.
¦The braided ccclusion devices may be made in a variety of ways, as should be apparent from the ¦discussion above. The devices may be strung on a guidewire or other similar device for installation, ¦10 necessitating that the braided tubular device have open ends for pascage of the guidewires. The ends may be closed if 80 desired.
The ultimate shape of the device is a matter of choice. We contemplate that it may be straight, as introduced into the body lumen, or may be C~ shaped, circular, figure ~8~, random, or any other shape desirable to the physician user in view of the physical situation to be resolved.
Modifications of the above-described variations for carrying out the invention which are obvious to those of ordinary skill in the fields of medical device design generally, and vasoocclusion devices specifically, are intended to be within the scope of the following claims.
. . - .
~ , .
. ... ; :: -.. . . .
'
Caps (122) and (124), variously in this configuration and in the others discussed herein, may be made of a radiopaque material such as platinum, tungsten, gold, silver, or alloys thereof, or other suitable generally radiopaque metals which are otherwise biologically inert. Radiopacity for the cap~ (122) and (124) is, of course, optional since the braid itself --contains radiopaque wires. The caps ~122) and (124) may be produced from a polymeric material or glue which seals the wires into the fibrous tubular element and keeps it from unraveling.
The diameter of the wire or fiber used in production of the braid will typically be in the range of 0.0005 and 0.005 lnches. The resulting woven braid diameter will normally be 0.008 to 0.018 inches.
Preferably, the braid diameter is 0.015 to 0.018 inches.
The wire may be a radlopaque material such as a metal or polymer, which polymer may be filled with a radiopaque material such a~ po~dered tantalum. Suitable metals and alloys include the platinum group metals especially 21135~7 platinum, rhodium, palladium, and tungsten, gold, silver, ~ tantalum, or alloys thereof. Preferred is a platinum-s tungsten alloy.
The wire may also be any of a variety of 5 stainless steels but may be made of other appropriate ~ materials including shape memory or highly elastic alloys i such as nickel-titanium alloys (48-58 atomic % nickel and 3 optionally containing modest amounts of iron); copper-zinc alloys (38.5-41.5 weight % zinc); copper-zinc alloys 10 containing 1-10 weight ~ of beryllium, silicon, tin, aluminum, or gallium; or nickel-aluminum alloys (36-38 atomic ~ aluminum). Particularly preferred are the alloy3 described in U.S. Pat Nos. 3,174,851, 3,351,463, and 3,753,700. Bspecially preferred is the Ti-Ni alloy 15 known as nitinol. Nitinol wire having the proper transition temperature allows the device to be introduced through the catheter in a linear fashion and upon raising the temperature of the vasoocclusive braid to body temperature, the wire in that braid assumes its pre-20 selected shape.
The radiolucent fibers may be made from biocompatible materials such as Dacron (polyester~, polyglycolic acid, polylactic acid, fluoropolymers (polytetrafluoroethylene), Nylon (polyamide), or silk.
25 The strands forming the braid should be reasonably heavy, e.g., having tensile strength of greater than about 0.15 pounds. Preferred materials are Dacron strands.
¦ The fibrous elements incorporated into the braid may be a bundle of individual fibers, e.g., between 30 5 and 100 flbers per fibrous bundle, preferably 20 to 30 fibers per bundle, or may be monofilaments.
The axial length of the braid will usually be in the range of 0.5 to 100 cm, more usually 2.5 to 40 cm.
Figure 3 shows another varlatlon of the inventive vasoocclusive device (140). In this variation, .. , ... ~
: , ,. . .~ . ~ . . .
2113587 ~
the tubular braid (142) contains a slightly higher incidence of radiopaque wires (12 a ) than the braid shown in Figure 2. This aspect is ~hown merely for the purpose of illustration. A3 noted above, the intent is to include at least radiopaque elements and optionally radiolucent elements which enhance the embolic features of the inventive braid. More importantly, Figure 3 shows the use of outlying fibers (144) which have been tied (or otherwise attached) to the tubular braid fibers. These fibers (144) are tied at various intervals to increase the propensity of the device to occlude blood. The outlying fibers (144) are typically Dacron but may be any of the natural and manmade fibers listed above.
Figure 4 shows another variation (150) of the inventive device in which tassels (152) are tied to the tubular braid to increase the breadth of the device and increase its overall clotting ability. These tassels are typically Dacron but, again, may be any of the fibrous materials described above. The tassels (152) may be short or long and may be singular or multiple depending upon the use intended.
Figure 5 shows a cutaway sideview of the invenSive device in which the braided tubular vasoocclusion device discussed above contains a core of radiolucent fibers. Although the fibers making up the braided tube may be radiolucent or radiopaque, the radiopaque fibers are preferred. The interior core of the braided tubular occlusion device (154) contains a bundle of radiolucent fibers (156) extending from one end of the braided tube to the other. The fiber bundle may be made up of fibers selected from those thermoplastics and natural materials noted above. The ends of the bundle may be ~ealed by heating those ends where the material~ 80 allow. The bundle may be pre-filled or infused with drugs ~ultable for later hastening of . , : : ,, ; . - . - .:
~, . . . .
coagulation after the device i8 introduced into the selected vascular site. The vasoocclusive device of IFigure 5 may also have outlying fibers attached to the !braided tubular element as has been discussed generally ! 5 above.
¦The braided ccclusion devices may be made in a variety of ways, as should be apparent from the ¦discussion above. The devices may be strung on a guidewire or other similar device for installation, ¦10 necessitating that the braided tubular device have open ends for pascage of the guidewires. The ends may be closed if 80 desired.
The ultimate shape of the device is a matter of choice. We contemplate that it may be straight, as introduced into the body lumen, or may be C~ shaped, circular, figure ~8~, random, or any other shape desirable to the physician user in view of the physical situation to be resolved.
Modifications of the above-described variations for carrying out the invention which are obvious to those of ordinary skill in the fields of medical device design generally, and vasoocclusion devices specifically, are intended to be within the scope of the following claims.
. . - .
~ , .
. ... ; :: -.. . . .
'
Claims (17)
1. A vasoocclusive device comprising a tubular member of braided fibers, at least a portion of said braided fibers being radiopaque, and having an interior cavity and a proximal and a distal end and which is of a size suitable for occluding a chosen site within the human vasculature.
2. The device of claim 1 where the tubular member braided fibers also comprise radiolucent fibers.
3. The device of claim 2 where the radiolucent fibers are selected from polyesters, polyglycolic acid, polylactic acid, fluoropolymers, polyamides, and silk.
4. The device of claim 3 where the radiolucent fibers comprise polyester.
5. The device of claim 1 where the radiopaque fibers comprise metals or polymers.
6. The device of claim 5 where the braided radiopaque fibers are selected from platinum, tungsten, gold, silver, tantalum, and alloys thereof, shape memory alloys, and stainless steels.
7. The device of claim 6 where the braided radiopaque fibers comprise a platinum-tungsten alloy.
8. The device of claim 6 where the braided radiopaque fibers comprise a shape memory alloy.
9. The device of claim 8 where at least a portion of the braided radiopaque fibers comprise nitinol.
10. The device of claim 1 additionally comprising braided fibers tied to the fibers in the braided tubular member.
11. The device of claim 10 where the fibers tied to the braided fibers are tied at multiple locations.
12. The device of claim 10 where the fibers tied to the braided fibers are tied so as to form tassels.
13. The device of claim 1 where the braided tubular member contains radiolucent fibers within the interior cavity.
14. The device of claim 13 where the radiolucent fibers in the interior cavity extend from the tubular member's distal end to the tubular member's proximal end.
15. The device of claim 13 where the radiolucent fibers in the interior cavity are selected from polyesters, polyglycolic acid, polylactic acid, fluoropolymers, polyamides, and silk.
16. The device of claim 15 where the radiolucent fibers in the interior cavity comprise polyester.
17. The device of claim 1 where the tubular member of braided fibers has a diameter of 0.015 to 0.018 inches.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US005,478 | 1993-01-15 | ||
US08/005,478 US5423849A (en) | 1993-01-15 | 1993-01-15 | Vasoocclusion device containing radiopaque fibers |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2113587A1 true CA2113587A1 (en) | 1994-07-16 |
Family
ID=21716084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002113587A Abandoned CA2113587A1 (en) | 1993-01-15 | 1994-01-17 | Vasoocculsion device containing radiopaque fibers |
Country Status (11)
Country | Link |
---|---|
US (1) | US5423849A (en) |
EP (1) | EP0679069B1 (en) |
JP (1) | JP2548514B2 (en) |
AT (1) | ATE224673T1 (en) |
AU (1) | AU669054B2 (en) |
CA (1) | CA2113587A1 (en) |
DE (1) | DE69332341T2 (en) |
ES (1) | ES2184757T3 (en) |
IL (1) | IL108182A0 (en) |
TW (1) | TW240165B (en) |
WO (1) | WO1994015534A1 (en) |
Families Citing this family (185)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995003010A1 (en) * | 1993-07-23 | 1995-02-02 | Cook Incorporated | A flexible stent having a pattern formed from a sheet of material |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
US6001123A (en) | 1994-04-01 | 1999-12-14 | Gore Enterprise Holdings Inc. | Folding self-expandable intravascular stent-graft |
JP2825452B2 (en) * | 1994-04-25 | 1998-11-18 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Radiopak stent marker |
JP4046760B2 (en) * | 1994-05-19 | 2008-02-13 | ボストン サイエンティフィック サイムド, インコーポレイテッド | Improved tissue support device |
US6331188B1 (en) | 1994-08-31 | 2001-12-18 | Gore Enterprise Holdings, Inc. | Exterior supported self-expanding stent-graft |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
EP0781114B1 (en) * | 1994-09-16 | 2005-05-25 | Ethicon Endo-Surgery, Inc. | Devices for defining and marking tissue |
NL9401533A (en) * | 1994-09-21 | 1996-05-01 | Cordis Europ | MR-visible catheter with elements of paramagnetic material. |
US5658264A (en) * | 1994-11-10 | 1997-08-19 | Target Therapeutics, Inc. | High performance spiral-wound catheter |
US5690671A (en) * | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
US6638291B1 (en) | 1995-04-20 | 2003-10-28 | Micrus Corporation | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US5911731A (en) * | 1995-04-20 | 1999-06-15 | Target Therapeutics, Inc. | Anatomically shaped vasoocclusive devices |
US5645558A (en) * | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US8790363B2 (en) * | 1995-04-20 | 2014-07-29 | DePuy Synthes Products, LLC | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US6824553B1 (en) | 1995-04-28 | 2004-11-30 | Target Therapeutics, Inc. | High performance braided catheter |
US5891112A (en) * | 1995-04-28 | 1999-04-06 | Target Therapeutics, Inc. | High performance superelastic alloy braid reinforced catheter |
US6705323B1 (en) | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US6176240B1 (en) | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US6689162B1 (en) * | 1995-10-11 | 2004-02-10 | Boston Scientific Scimed, Inc. | Braided composite prosthesis |
US5658308A (en) * | 1995-12-04 | 1997-08-19 | Target Therapeutics, Inc. | Bioactive occlusion coil |
US6042605A (en) | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
DE69637245T2 (en) * | 1995-12-14 | 2008-06-12 | Gore Enterprise Holdings, Inc., Newark | Crease resistant stent rail |
JP2000503559A (en) | 1995-12-14 | 2000-03-28 | ゴア エンタープライズ ホールディングス,インコーポレイティド | Apparatus and method for deploying a stent-graft |
US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5718159A (en) * | 1996-04-30 | 1998-02-17 | Schneider (Usa) Inc. | Process for manufacturing three-dimensional braided covered stent |
US6592617B2 (en) * | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US6270477B1 (en) | 1996-05-20 | 2001-08-07 | Percusurge, Inc. | Catheter for emboli containment |
US6174329B1 (en) | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US5964797A (en) * | 1996-08-30 | 1999-10-12 | Target Therapeutics, Inc. | Electrolytically deployable braided vaso-occlusion device |
US6096052A (en) * | 1998-07-08 | 2000-08-01 | Ovion, Inc. | Occluding device and method of use |
US20010041900A1 (en) * | 1999-12-21 | 2001-11-15 | Ovion, Inc. | Occluding device and method of use |
US7073504B2 (en) | 1996-12-18 | 2006-07-11 | Ams Research Corporation | Contraceptive system and method of use |
US6352561B1 (en) | 1996-12-23 | 2002-03-05 | W. L. Gore & Associates | Implant deployment apparatus |
US6551350B1 (en) | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US5925061A (en) | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
US5858556A (en) * | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US5919224A (en) * | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
US20020133222A1 (en) * | 1997-03-05 | 2002-09-19 | Das Gladwin S. | Expandable stent having a plurality of interconnected expansion modules |
US6776792B1 (en) | 1997-04-24 | 2004-08-17 | Advanced Cardiovascular Systems Inc. | Coated endovascular stent |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US5746691A (en) | 1997-06-06 | 1998-05-05 | Global Therapeutics, Inc. | Method for polishing surgical stents |
US6174330B1 (en) | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US5980564A (en) * | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
US6340367B1 (en) | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
US6156061A (en) * | 1997-08-29 | 2000-12-05 | Target Therapeutics, Inc. | Fast-detaching electrically insulated implant |
US6168570B1 (en) | 1997-12-05 | 2001-01-02 | Micrus Corporation | Micro-strand cable with enhanced radiopacity |
US6241691B1 (en) | 1997-12-05 | 2001-06-05 | Micrus Corporation | Coated superelastic stent |
US6159165A (en) | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
US6626939B1 (en) * | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US7070607B2 (en) | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
US5935145A (en) * | 1998-02-13 | 1999-08-10 | Target Therapeutics, Inc. | Vaso-occlusive device with attached polymeric materials |
US5925060A (en) | 1998-03-13 | 1999-07-20 | B. Braun Celsa | Covered self-expanding vascular occlusion device |
DK0986334T3 (en) | 1998-04-07 | 2005-01-24 | Cook Inc | Device for carocclusion with an asymmetric plurality of fibers |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US7004962B2 (en) * | 1998-07-27 | 2006-02-28 | Schneider (Usa), Inc. | Neuroaneurysm occlusion and delivery device and method of using same |
US6187024B1 (en) | 1998-11-10 | 2001-02-13 | Target Therapeutics, Inc. | Bioactive coating for vaso-occlusive devices |
US8016852B2 (en) * | 1998-11-10 | 2011-09-13 | Stryker Corporation | Bioactive components for incorporation with vaso-occlusive members |
US6083259A (en) * | 1998-11-16 | 2000-07-04 | Frantzen; John J. | Axially non-contracting flexible radially expandable stent |
US6187034B1 (en) | 1999-01-13 | 2001-02-13 | John J. Frantzen | Segmented stent for flexible stent delivery system |
US6022359A (en) * | 1999-01-13 | 2000-02-08 | Frantzen; John J. | Stent delivery system featuring a flexible balloon |
US20020138094A1 (en) * | 1999-02-12 | 2002-09-26 | Thomas Borillo | Vascular filter system |
US6620192B1 (en) * | 1999-03-16 | 2003-09-16 | Advanced Cardiovascular Systems, Inc. | Multilayer stent |
US6464723B1 (en) | 1999-04-22 | 2002-10-15 | Advanced Cardiovascular Systems, Inc. | Radiopaque stents |
ATE377395T1 (en) * | 1999-06-02 | 2007-11-15 | Sethel Interventional Inc | INTRACORPORAL CLOSURE DEVICE |
US6280457B1 (en) * | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
US7229462B2 (en) * | 1999-07-30 | 2007-06-12 | Angioguard, Inc. | Vascular filter system for carotid endarterectomy |
US7229463B2 (en) * | 1999-07-30 | 2007-06-12 | Angioguard, Inc. | Vascular filter system for cardiopulmonary bypass |
US6709667B1 (en) | 1999-08-23 | 2004-03-23 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
US6585757B1 (en) | 1999-09-15 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Endovascular stent with radiopaque spine |
DE19952505A1 (en) * | 1999-10-29 | 2001-05-03 | Gerd Hausdorf | An expandable balloon for medical use comprises a thin-walled polymer shell coated with radio-opaque material in a pattern and is expandable on introduction of liquid and increasing pressure |
US6602287B1 (en) | 1999-12-08 | 2003-08-05 | Advanced Cardiovascular Systems, Inc. | Stent with anti-thrombogenic coating |
WO2001066167A2 (en) * | 2000-03-03 | 2001-09-13 | Chuter Timothy A M | Large vessel stents and occluders |
US6656200B2 (en) | 2000-04-07 | 2003-12-02 | Collagen Matrix, Inc. | Embolization device |
US6652579B1 (en) | 2000-06-22 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
US6695833B1 (en) * | 2000-09-27 | 2004-02-24 | Nellix, Inc. | Vascular stent-graft apparatus and forming method |
US20030004533A1 (en) | 2001-05-04 | 2003-01-02 | Concentric Medical | Bioactive polymer vaso-occlusive device |
US7150737B2 (en) | 2001-07-13 | 2006-12-19 | Sci/Med Life Systems, Inc. | Methods and apparatuses for navigating the subarachnoid space |
US20030093105A1 (en) * | 2001-07-13 | 2003-05-15 | Scimed Life Systems, Inc. | Guide catheter for introduction into the subarachnoid space and methods of use thereof |
US7011647B2 (en) * | 2001-07-13 | 2006-03-14 | Scimed Life Systems, Inc. | Introducer sheath |
US7455666B2 (en) | 2001-07-13 | 2008-11-25 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
JP2003048841A (en) * | 2001-08-03 | 2003-02-21 | Yasuhiko Tabata | Composition for blocking blood vessel |
FR2832307B1 (en) * | 2001-11-19 | 2004-08-27 | Sofradim Production | DEVICE FOR OCCLUSIONING A BODILY CONDUIT, IN PARTICULAR A VARIOUS VEIN |
EP1542616B1 (en) * | 2002-09-20 | 2015-04-22 | Endologix, Inc. | Stent-graft with positioning anchor |
WO2004058110A2 (en) * | 2002-12-24 | 2004-07-15 | Ovion, Inc. | Contraceptive device and delivery system |
CA2525792C (en) | 2003-05-15 | 2015-10-13 | Biomerix Corporation | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
CA2484906C (en) * | 2003-10-17 | 2012-12-04 | Tyco Healthcare Group Lp | Surgical access device and manufacture thereof |
US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
EP1711143B1 (en) * | 2004-02-02 | 2013-04-10 | Conceptus, Inc. | Contraceptive with permeable and impermeable components |
US20060009798A1 (en) * | 2004-02-02 | 2006-01-12 | Ams Research Corporation | Methods and devices for occluding body lumens and/or enhancing tissue ingrowth |
CA2779044C (en) * | 2004-04-28 | 2014-12-16 | Conceptus, Inc. | Endoscopic delivery of medical devices |
CA2567331C (en) * | 2004-05-21 | 2012-08-14 | Microtherapeutics, Inc. | Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity |
US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
EP2419048A4 (en) | 2004-05-25 | 2014-04-09 | Covidien Lp | Vascular stenting for aneurysms |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
WO2005115118A2 (en) | 2004-05-25 | 2005-12-08 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US7749242B2 (en) * | 2004-06-21 | 2010-07-06 | Boston Scientific Scimed, Inc. | Expanding vaso-occlusive device |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
EP1793744B1 (en) | 2004-09-22 | 2008-12-17 | Dendron GmbH | Medical implant |
ATE448737T1 (en) | 2004-09-22 | 2009-12-15 | Dendron Gmbh | DEVICE FOR IMPLANTING MICROWL COILS |
US20080140184A1 (en) * | 2004-09-30 | 2008-06-12 | Pellegrino-Gensey J Lee | Scaffold device |
US20060089672A1 (en) * | 2004-10-25 | 2006-04-27 | Jonathan Martinek | Yarns containing filaments made from shape memory alloys |
US7455688B2 (en) * | 2004-11-12 | 2008-11-25 | Con Interventional Systems, Inc. | Ostial stent |
WO2006055967A2 (en) * | 2004-11-19 | 2006-05-26 | Lumen Biomedical, Inc. | Extendable device on an aspiration catheter |
US8771294B2 (en) | 2004-11-26 | 2014-07-08 | Biomerix Corporation | Aneurysm treatment devices and methods |
DE102005007341B4 (en) * | 2005-02-17 | 2007-10-11 | Kasprzak, Piotr, Dr. | Stent prosthesis for vascular surgery, especially in the area of the aortic arch |
DE102005019782A1 (en) * | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Device for implantation of occlusion coils with internal securing means |
CA2604081C (en) | 2005-05-25 | 2013-11-26 | Chestnut Medical Technologies, Inc. | System and method for delivering and deploying a self-expanding device within a vessel |
US8273101B2 (en) * | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
EP1903985A4 (en) | 2005-07-07 | 2010-04-28 | Nellix Inc | Systems and methods for endovascular aneurysm treatment |
US8052714B2 (en) * | 2005-11-22 | 2011-11-08 | Medtronic Vascular, Inc. | Radiopaque fibers and filtration matrices |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US8152833B2 (en) | 2006-02-22 | 2012-04-10 | Tyco Healthcare Group Lp | Embolic protection systems having radiopaque filter mesh |
US20070219618A1 (en) * | 2006-03-17 | 2007-09-20 | Cully Edward H | Endoprosthesis having multiple helically wound flexible framework elements |
US8235047B2 (en) * | 2006-03-30 | 2012-08-07 | Conceptus, Inc. | Methods and devices for deployment into a lumen |
CN101448464B (en) | 2006-04-17 | 2011-05-04 | 微治疗公司 | System and method for mechanically positioning intravascular implants |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
CA2679112C (en) * | 2007-03-05 | 2015-08-11 | Boston Scientific Limited | Deploying embolic coils |
ES2437619T3 (en) | 2007-03-13 | 2014-01-13 | Covidien Lp | An implant that includes a helical winding and a stretch resistant element |
CA2680793C (en) | 2007-03-13 | 2015-07-07 | Microtherapeutics, Inc. | An implant, a mandrel, and a method of forming an implant |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
EP2234562B1 (en) | 2007-12-21 | 2019-02-27 | MicroVention, Inc. | A system and method of detecting implant detachment |
EP2231030B1 (en) | 2007-12-21 | 2019-02-27 | MicroVention, Inc. | System and method for locating detachment zone of a detachable implant |
AU2009240419A1 (en) | 2008-04-25 | 2009-10-29 | Nellix, Inc. | Stent graft delivery system |
WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
CA2726596A1 (en) | 2008-06-04 | 2009-12-10 | Nellix, Inc. | Sealing apparatus and methods of use |
FR2943905B1 (en) * | 2009-04-06 | 2011-04-22 | Braun Medical Sas | EMBOLIZATION IMPLANT |
US20110092955A1 (en) | 2009-10-07 | 2011-04-21 | Purdy Phillip D | Pressure-Sensing Medical Devices, Systems and Methods, and Methods of Forming Medical Devices |
US20110276078A1 (en) | 2009-12-30 | 2011-11-10 | Nellix, Inc. | Filling structure for a graft system and methods of use |
CA2795740C (en) | 2010-04-14 | 2018-03-13 | Microvention, Inc. | Implant delivery device |
US8801768B2 (en) | 2011-01-21 | 2014-08-12 | Endologix, Inc. | Graft systems having semi-permeable filling structures and methods for their use |
RU2599592C2 (en) | 2011-02-04 | 2016-10-10 | Концентрик Медикал, Инк. | Device for embolic occlusion extraction |
CN103648437B (en) | 2011-04-06 | 2016-05-04 | 恩朵罗杰克斯国际控股有限公司 | For the method and system of vascular aneurysms treatment |
US9173736B2 (en) | 2011-04-28 | 2015-11-03 | Medtronic Vascular, Inc. | Method of making an endoluminal vascular prosthesis |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
WO2013119332A2 (en) | 2012-02-09 | 2013-08-15 | Stout Medical Group, L.P. | Embolic device and methods of use |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9301831B2 (en) | 2012-10-30 | 2016-04-05 | Covidien Lp | Methods for attaining a predetermined porosity of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9119948B2 (en) | 2013-02-20 | 2015-09-01 | Covidien Lp | Occlusive implants for hollow anatomical structures, delivery systems, and related methods |
US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
WO2014159093A1 (en) | 2013-03-14 | 2014-10-02 | Endologix, Inc. | Method for forming materials in situ within a medical device |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
CN116172656A (en) | 2013-03-15 | 2023-05-30 | 伊瑟拉医疗公司 | Vascular treatment devices and methods |
US8690907B1 (en) | 2013-03-15 | 2014-04-08 | Insera Therapeutics, Inc. | Vascular treatment methods |
WO2017142874A2 (en) | 2016-02-16 | 2017-08-24 | Insera Therapeutics, Inc. | Aspiration devices and anchored flow diverting devices |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
US9060777B1 (en) | 2014-05-28 | 2015-06-23 | Tw Medical Technologies, Llc | Vaso-occlusive devices and methods of use |
EP3148481A4 (en) | 2014-05-28 | 2017-05-03 | Stryker European Holdings I, LLC | Vaso-occlusive devices and methods of use |
AU2015292327A1 (en) | 2014-07-25 | 2017-02-16 | Incumedx, Inc. | Covered embolic coils |
US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
US10736730B2 (en) | 2015-01-20 | 2020-08-11 | Neurogami Medical, Inc. | Vascular implant |
US10925611B2 (en) | 2015-01-20 | 2021-02-23 | Neurogami Medical, Inc. | Packaging for surgical implant |
US11484319B2 (en) | 2015-01-20 | 2022-11-01 | Neurogami Medical, Inc. | Delivery system for micrograft for treating intracranial aneurysms |
EP3247285B1 (en) | 2015-01-20 | 2021-08-11 | Neurogami Medical, Inc. | Micrograft for the treatment of intracranial aneurysms |
US10857012B2 (en) | 2015-01-20 | 2020-12-08 | Neurogami Medical, Inc. | Vascular implant |
WO2016182949A1 (en) | 2015-05-08 | 2016-11-17 | Stryker European Holdings I, Llc | Vaso-occlusive devices |
CN108135686B (en) * | 2015-09-10 | 2021-06-04 | 纳米纤维解决方案股份有限公司 | Polymer electrospinning embolization devices and methods of use |
EP3370788A4 (en) | 2015-11-02 | 2019-07-31 | Nanofiber Solutions, LLC | Electrospun fibers having contrast agents and methods of making the same |
CN105433991B (en) * | 2015-12-28 | 2018-12-07 | 先健科技(深圳)有限公司 | Plugging device |
WO2017214431A2 (en) * | 2016-06-10 | 2017-12-14 | Stryker Corporation | Braided medical devices |
US10420563B2 (en) | 2016-07-08 | 2019-09-24 | Neurogami Medical, Inc. | Delivery system insertable through body lumen |
US10076428B2 (en) | 2016-08-25 | 2018-09-18 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
US10292851B2 (en) | 2016-09-30 | 2019-05-21 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
WO2018217653A1 (en) | 2017-05-22 | 2018-11-29 | Boston Scientific Scimed, Inc. | Devices and methods of use with devices having a radiopaque filament |
AU2019204522A1 (en) | 2018-07-30 | 2020-02-13 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US10456280B1 (en) | 2018-08-06 | 2019-10-29 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US10278848B1 (en) | 2018-08-06 | 2019-05-07 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
US20210267644A1 (en) * | 2020-03-02 | 2021-09-02 | Cleveland State University | Metal plate with one-way shape memory effect |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3105492A (en) * | 1958-10-01 | 1963-10-01 | Us Catheter & Instr Corp | Synthetic blood vessel grafts |
US3272204A (en) * | 1965-09-22 | 1966-09-13 | Ethicon Inc | Absorbable collagen prosthetic implant with non-absorbable reinforcing strands |
US3826171A (en) * | 1970-04-20 | 1974-07-30 | J Kaar | Guitar string |
JPS6028434Y2 (en) * | 1980-06-16 | 1985-08-28 | 建部 容保 | Artificial blood vessel |
US4364392A (en) * | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US5190546A (en) * | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US4798606A (en) * | 1985-02-26 | 1989-01-17 | Corvita Corporation | Reinforcing structure for cardiovascular graft |
US4629458A (en) * | 1985-02-26 | 1986-12-16 | Cordis Corporation | Reinforcing structure for cardiovascular graft |
US4708718A (en) * | 1985-07-02 | 1987-11-24 | Target Therapeutics | Hyperthermic treatment of tumors |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4762922A (en) * | 1987-07-01 | 1988-08-09 | Squibb Corporation | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines |
US4820298A (en) * | 1987-11-20 | 1989-04-11 | Leveen Eric G | Internal vascular prosthesis |
US4877030A (en) * | 1988-02-02 | 1989-10-31 | Andreas Beck | Device for the widening of blood vessels |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5071407A (en) * | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5108407A (en) * | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
US5167624A (en) * | 1990-11-09 | 1992-12-01 | Catheter Research, Inc. | Embolus delivery system and method |
US5217484A (en) * | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
US5226911A (en) * | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5256146A (en) * | 1991-10-11 | 1993-10-26 | W. D. Ensminger | Vascular catheterization system with catheter anchoring feature |
US5261916A (en) * | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
US5250071A (en) * | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
-
1993
- 1993-01-15 US US08/005,478 patent/US5423849A/en not_active Expired - Lifetime
- 1993-12-22 WO PCT/US1993/012515 patent/WO1994015534A1/en active IP Right Grant
- 1993-12-22 ES ES94905949T patent/ES2184757T3/en not_active Expired - Lifetime
- 1993-12-22 AT AT94905949T patent/ATE224673T1/en not_active IP Right Cessation
- 1993-12-22 DE DE69332341T patent/DE69332341T2/en not_active Expired - Lifetime
- 1993-12-22 EP EP94905949A patent/EP0679069B1/en not_active Expired - Lifetime
- 1993-12-22 AU AU59858/94A patent/AU669054B2/en not_active Ceased
- 1993-12-27 IL IL10818293A patent/IL108182A0/en unknown
-
1994
- 1994-01-14 JP JP6002838A patent/JP2548514B2/en not_active Expired - Lifetime
- 1994-01-17 CA CA002113587A patent/CA2113587A1/en not_active Abandoned
- 1994-02-19 TW TW083101408A patent/TW240165B/zh active
Also Published As
Publication number | Publication date |
---|---|
IL108182A0 (en) | 1994-04-12 |
JP2548514B2 (en) | 1996-10-30 |
EP0679069A4 (en) | 1996-07-24 |
TW240165B (en) | 1995-02-11 |
DE69332341T2 (en) | 2003-01-23 |
WO1994015534A1 (en) | 1994-07-21 |
AU669054B2 (en) | 1996-05-23 |
JPH0759787A (en) | 1995-03-07 |
EP0679069B1 (en) | 2002-09-25 |
ES2184757T3 (en) | 2003-04-16 |
AU5985894A (en) | 1994-08-15 |
ATE224673T1 (en) | 2002-10-15 |
US5423849A (en) | 1995-06-13 |
EP0679069A1 (en) | 1995-11-02 |
DE69332341D1 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5423849A (en) | Vasoocclusion device containing radiopaque fibers | |
JP2553309B2 (en) | Vascular occlusion device with tubular cover of woven or knitted fibers | |
AU656283B2 (en) | Vasoocclusion coil with attached fibrous element(s) | |
EP0964648B1 (en) | Vaso-occlusive coil with conical ends | |
JP2908363B2 (en) | Bioactive occlusion coil | |
US5582619A (en) | Stretch resistant vaso-occlusive coils | |
CA2084749C (en) | Vasoocclusion coil with attached fibrous element(s) | |
EP0754435A1 (en) | Stretch-resistant vaso-occlusive coils | |
JP2002507902A (en) | Stretch-resistant vasoocclusive coil (II) | |
EP0715503A1 (en) | Vasoocclusive coils with thrombogenic enhancing fibers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |